That would have been,imo, price sensitive due to the voucher.
Is it just your opinion or have I missed something?
Reg
- Forums
- ASX - By Stock
- MSB
- Ann: Meeting Requested with FDA on Revascor Accelerated Approval
MSB
mesoblast limited
Add to My Watchlist
1.92%
!
$1.79

Ann: Meeting Requested with FDA on Revascor Accelerated Approval, page-24
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.79 |
Change
-0.035(1.92%) |
Mkt cap ! $2.293B |
Open | High | Low | Value | Volume |
$1.80 | $1.83 | $1.76 | $4.860M | 2.722M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 28395 | $1.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.79 | 19463 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 14 | 1.785 |
13 | 35980 | 1.780 |
13 | 27326 | 1.775 |
10 | 31706 | 1.770 |
11 | 105700 | 1.765 |
Price($) | Vol. | No. |
---|---|---|
1.790 | 35612 | 15 |
1.795 | 13674 | 6 |
1.800 | 84235 | 11 |
1.805 | 95309 | 7 |
1.810 | 50410 | 3 |
Last trade - 11.36am 18/06/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online